BCEL
Price:
$0.09
Market Cap:
$3.57M
Atreca, Inc. is a clinical-stage biopharmaceutical firm dedicated to discovering and advancing antibody-based immunotherapies for various solid tumor indications. Its lead investigational therapeutic, ATRC-101, is a monoclonal antibody distinguished by its novel mechanism of action and a unique target, both identified through the company's proprietary discovery platform. In in vitro studies, ATRC-101 has demonstrated reactivity with a significant proportion of human ovarian, non-small cell lung, colorectal, and breast cancer samples sourced from diverse patient populations. The pipeline also includes APN-122597, a receptor tyrosine kinase engineered to specifically target tumor tissues, and ...[Read more]
Industry
Biotechnology
IPO Date
2019-06-20
Stock Exchange
NASDAQ
Ticker
BCEL
According to Atreca, Inc.’s latest financial reports and current stock price. The company's current ROE is -83.28%. This represents a change of -24.51% compared to the average of -110.31% of the last 4 quarters.
The mean historical ROE of Atreca, Inc. over the last ten years is -41.67%. The current -83.28% ROE has changed 99.86% with respect to the historical average. Over the past ten years (40 quarters), BCEL's ROE was at its highest in in the March 2018 quarter at 0%. The ROE was at its lowest in in the September 2023 quarter at -336.60%.
Average
-41.67%
Median
-35.88%
Minimum
-123.92%
Maximum
48.66%
Discovering the peaks and valleys of Atreca, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 97.84%
Maximum Annual ROE = 48.66%
Minimum Annual Increase = -166.63%
Minimum Annual ROE = -123.92%
| Year | ROE | Change |
|---|---|---|
| 2022 | -123.92% | 75.60% |
| 2021 | -70.57% | 97.84% |
| 2020 | -35.67% | -1.19% |
| 2019 | -36.10% | 11.33% |
| 2018 | -32.42% | -166.63% |
The current ROE of Atreca, Inc. (BCEL) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-76.72%
5-year avg
-59.73%
10-year avg
-41.67%
Atreca, Inc.’s ROE is greater than Gritstone bio, Inc. (-124.41%), greater than Idera Pharmaceuticals, Inc. (-113.18%), greater than RVL Pharmaceuticals plc (-80.88%), greater than Affimed N.V. (-100.55%), greater than Unity Biotechnology, Inc. (-500.62%), greater than VivoSim Labs, Inc. (-15.56%), less than Q32 Bio Inc. (230.68%), greater than Onconetix, Inc. (-105.46%), greater than Aravive, Inc. (-306.06%), less than Gamida Cell Ltd. (1.15%),
| Company | ROE | Market cap |
|---|---|---|
| -124.41% | $3.80M | |
| -113.18% | $0 | |
| -80.88% | $3.14M | |
| -100.55% | $2.98M | |
| -500.62% | $3.44M | |
| -15.56% | $2.87M | |
| 230.68% | $152.04M | |
| -105.46% | $315.29K | |
| -306.06% | $2.95M | |
| 1.15% | $4.34M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Atreca, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Atreca, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Atreca, Inc.'s ROE?
How is the ROE calculated for Atreca, Inc. (BCEL)?
What is the highest ROE for Atreca, Inc. (BCEL)?
What is the 3-year average ROE for Atreca, Inc. (BCEL)?
What is the 5-year average ROE for Atreca, Inc. (BCEL)?
How does the current ROE for Atreca, Inc. (BCEL) compare to its historical average?